Nuria García-Font

Toxicological and pharmacological evaluation, antioxidant, ADMET and molecular modeling of selected racemic chromenotacrines {11-amino-12-aryl-8,9,10,12-tetrahydro-7H-chromeno[2,3-b]quinolin-3-ols} for the potential prevention and treatment of Alzheimer's disease

María Jesús Oset‐Gasque, María Pilar González, Javier Pérez‐Peña et al. · European Journal of Medicinal Chemistry · 2014 · 54 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Potent anticholinesterasic and neuroprotective pyranotacrines as inhibitors of beta-amyloid aggregation, oxidative stress and tau-phosphorylation for Alzheimer's disease

Nuria García-Font, H. Hayour, Ali Belfaitah et al. · European Journal of Medicinal Chemistry · 2016 · 51 citations · Full text

Medicine, Neuroscience, Pharmacology +16

Avarol derivatives as competitive AChE inhibitors, non hepatotoxic and neuroprotective agents for Alzheimer’s disease

Giuseppina Tommonaro, Nuria García-Font, Rosa Maria Vitale et al. · European Journal of Medicinal Chemistry · 2016 · 49 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

β-Adrenergic Receptors/Epac Signaling Increases the Size of the Readily Releasable Pool of Synaptic Vesicles Required for Parallel Fiber LTP

Ricardo Martín, Nuria García-Font, Alberto Samuel Suárez-Pinilla et al. · Journal of Neuroscience · 2020 · 35 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43

Irene B. Maroto, Carlos Costas‐Insua, Coralie Berthoux et al. · Nature Communications · 2023 · 22 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16